Cargando…

Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course

BACKGROUND: We reported previously that (18)F-2-fluoro-2-deoxyglucose positron emission tomography/ computed tomography (FDG PET/CT) had potential for evaluating early response to treatment by tyrosine kinase inhibitors (TKIs) in advanced renal cell carcinoma (RCC). This time we investigated the rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueno, Daiki, Yao, Masahiro, Tateishi, Ukihide, Minamimoto, Ryogo, Makiyama, Kazuhide, Hayashi, Narihiko, Sano, Futoshi, Murakami, Takayuki, Kishida, Takeshi, Miura, Takeshi, Kobayashi, Kazuki, Noguchi, Sumio, Ikeda, Ichiro, Ohgo, Yoshiharu, Inoue, Tomio, Kubota, Yoshinobu, Nakaigawa, Noboru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418566/ https://www.ncbi.nlm.nih.gov/pubmed/22551397 http://dx.doi.org/10.1186/1471-2407-12-162

Ejemplares similares

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
por: Kakizoe, Manabu, et al.
Publicado: (2014)

Impact of maximum Standardized Uptake Value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report
por: Namura, Kazuhiro, et al.
Publicado: (2010)

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma
por: Nakaigawa, Noboru, et al.
Publicado: (2016)

The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy
por: Nakaigawa, Noboru, et al.
Publicado: (2017)

C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy
por: Ito, Hiroki, et al.
Publicado: (2012)

Retroperitoneoscopic radical nephrectomy with a small incision for renal cell carcinoma: Comparison with the conventional method
por: Ito, Hiroki, et al.
Publicado: (2011)

The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer
por: Tatenuma, Tomoyuki, et al.
Publicado: (2019)

Laparoscopic Nephroureterectomy for Adult Patient with Primary Obstructive Megaureter
por: Osaka, Kimito, et al.
Publicado: (2013)

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas
por: Yao, Masahiro, et al.
Publicado: (2014)

Primary Synovial Sarcoma of the Kidney
por: Kawahara, Takashi, et al.
Publicado: (2009)

Gallbladder Metastasis from Renal Cell Carcinoma
por: Kawahara, Takashi, et al.
Publicado: (2010)

Neuroendocrine Carcinoma of the Bladder
por: Kawahara, Takashi, et al.
Publicado: (2010)

Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT
por: Minamimoto, Ryogo
Publicado: (2021)

Correlation of urinary loss rate after catheter removal and long‐term urinary continence after robot‐assisted laparoscopic radical prostatectomy
por: Tatenuma, Tomoyuki, et al.
Publicado: (2021)

Roughness of the renal tumor surface could predict the surgical difficulty of robot‐assisted partial nephrectomy
por: Tatenuma, Tomoyuki, et al.
Publicado: (2022)

Real-World Data on the Effectiveness of Microporous Polysaccharide Hemospheres for Allowing Even Novice Surgeons to Perform Robot-Assisted Radical Prostatectomy Safely
por: Nirei, Takuma, et al.
Publicado: (2023)

Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey
por: Minamimoto, Ryogo, et al.
Publicado: (2014)

Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review
por: Minamimoto, Ryogo
Publicado: (2022)

Renal Cell Carcinoma in a Horseshoe Kidney Treated with Laparoscopic Partial Nephrectomy
por: Ohtake, Shinji, et al.
Publicado: (2018)

Preparation for pyeloplasty for ureteropelvic junction obstruction using a patient-specific laparoscopic simulator: a case report
por: Yamanaka, Hiroyuki, et al.
Publicado: (2012)

Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
por: Noguchi, Go, et al.
Publicado: (2018)

The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006–2009) nationwide survey
por: Minamimoto, Ryogo, et al.
Publicado: (2012)

Early assessment with (18)F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab
por: Tabei, Tadashi, et al.
Publicado: (2019)

Prediction of open urinary tract in laparoscopic partial nephrectomy by virtual resection plane visualization
por: Ueno, Daiki, et al.
Publicado: (2014)

Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
por: Toyama, Yoshitaka, et al.
Publicado: (2020)

Nonfunctioning Juxtaglomerular Cell Tumor
por: Sakata, Ryoko, et al.
Publicado: (2013)

Comparison of [(18)F]FDG PET/CT and MRI for Treatment Response Assessment in Multiple Myeloma: A Meta-Analysis
por: Yokoyama, Kota, et al.
Publicado: (2021)

The impact of gender difference on operative time in laparoscopic partial nephrectomy for T1 renal tumor and the utility of retroperitoneal fat thickness as a predictor of operative time
por: Ito, Hiroki, et al.
Publicado: (2016)

Use of Sotrovimab for COVID-19 in a Patient with International Germ Cell Consensus Classification Poor Prognosis Testicular Germ Cell Tumor
por: Nagasaka, Hirotaka, et al.
Publicado: (2023)

Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma
por: Minamimoto, Ryogo, et al.
Publicado: (2016)

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Tateishi, Kensuke, et al.
Publicado: (2020)

A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma
por: Noguchi, Go, et al.
Publicado: (2020)

Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014)

CS-03 BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Hayashi, Takahiro, et al.
Publicado: (2020)

Seventy FDG-PET/CT Cases in Which Nuclear Medicine Physicians Suspected Lymphoma: How Reliable Are We?
por: Toriihara, Akira, et al.
Publicado: (2017)

Risk Factors for Metastatic Castration-Resistant Prostate Cancer (CRPC) Predict Long-Term Treatment with Docetaxel
por: Kawahara, Takashi, et al.
Publicado: (2012)

Diagnostic performance of (18)F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI
por: Hotta, Masatoshi, et al.
Publicado: (2018)

Additional Value of [(18)F]FDG PET or PET/CT for Response Assessment of Patients with Gastrointestinal Stromal Tumor Undergoing Molecular Targeted Therapy: A Meta-Analysis
por: Yokoyama, Kota, et al.
Publicado: (2021)

Proliferation PET/CT Imaging of Salivary Gland Tumor
por: Minamimoto, Ryogo
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_utb8vmeec0qtrdc2t5lbhmujlr